MedPage Today on MSN
Dramatic results seen with gene therapy for age-related macular degeneration
Stable vision and retinal anatomy for up to 5 years, no supplemental therapy for up to 2 y ...
Add Yahoo as a preferred source to see more of our stories on Google. Dr Dao Nguyen examines a vial of lutein formulation developed for potential use in eyedrop treatments. (CREDIT: Will Wright, RMIT ...
Australian scientists have successfully used an innovative gene therapy technique in the lab to combat a key cause of vision loss in "wet" age-related macular degeneration and diabetic eye disease.
Many surgeons admit that medical robots can now operate with greater precision than human specialists. However, the complex preparation required for robotic surgery still takes far too long. But a new ...
What Is Eylea, and Why Does It Matter? Eylea HD (aflibercept) is an injectable prescription medicine used for treating certain eye conditions that can cause vision loss over time. The FDA has now ...
Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results